Obesity Treatment-Global Market Status and Trend Report 2013-2023
Report Summary
Obesity Treatment-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Obesity Treatment worldwide, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the global Obesity Treatment market as:
Global Obesity Treatment Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Obesity Treatment Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Global Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
Global Obesity Treatment Market: Manufacturers Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Obesity Treatment-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Obesity Treatment industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Obesity Treatment 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Obesity Treatment worldwide, with company and product introduction, position in the Obesity Treatment market
Market status and development trend of Obesity Treatment by types and applications
Cost and profit status of Obesity Treatment, and marketing status
Market growth drivers and challenges
The report segments the global Obesity Treatment market as:
Global Obesity Treatment Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Obesity Treatment Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Global Obesity Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children
Adults
Global Obesity Treatment Market: Manufacturers Segment Analysis (Company and Product introduction, Obesity Treatment Sales Volume, Revenue, Price and Gross Margin):
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OBESITY TREATMENT
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 Global Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Obesity Treatment 2013-2017
2.2 Production Market of Obesity Treatment by Regions
2.2.1 Production Volume of Obesity Treatment by Regions
2.2.2 Production Value of Obesity Treatment by Regions
2.3 Demand Market of Obesity Treatment by Regions
2.4 Production and Demand Status of Obesity Treatment by Regions
2.4.1 Production and Demand Status of Obesity Treatment by Regions 2013-2017
2.4.2 Import and Export Status of Obesity Treatment by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Obesity Treatment by Types
3.2 Production Value of Obesity Treatment by Types
3.3 Market Forecast of Obesity Treatment by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Obesity Treatment by Downstream Industry
4.2 Market Forecast of Obesity Treatment by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
5.1 Global Economy Situation and Trend Overview
5.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 6 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Obesity Treatment by Major Manufacturers
6.2 Production Value of Obesity Treatment by Major Manufacturers
6.3 Basic Information of Obesity Treatment by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Obesity Treatment Major Manufacturer
6.3.2 Employees and Revenue Level of Obesity Treatment Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 NutriSystem, Inc. (U.S.)
7.1.1 Company profile
7.1.2 Representative Obesity Treatment Product
7.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
7.2 Kellogg Company (U.S.)
7.2.1 Company profile
7.2.2 Representative Obesity Treatment Product
7.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
7.3 Ethicon, Inc. (U.S.)
7.3.1 Company profile
7.3.2 Representative Obesity Treatment Product
7.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
7.4 Medtronic (U.S.)
7.4.1 Company profile
7.4.2 Representative Obesity Treatment Product
7.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 Company profile
7.5.2 Representative Obesity Treatment Product
7.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Company profile
7.6.2 Representative Obesity Treatment Product
7.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
7.7 Herbalife Ltd. (U.S.)
7.7.1 Company profile
7.7.2 Representative Obesity Treatment Product
7.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
7.8 Covidien plc (U.S.)
7.8.1 Company profile
7.8.2 Representative Obesity Treatment Product
7.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
7.9 Apollo Endosurgery (U.S.)
7.9.1 Company profile
7.9.2 Representative Obesity Treatment Product
7.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
7.10 Amer Sports (Finland)
7.10.1 Company profile
7.10.2 Representative Obesity Treatment Product
7.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Company profile
7.11.2 Representative Obesity Treatment Product
7.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
7.12 Cybex International (U.S.)
7.12.1 Company profile
7.12.2 Representative Obesity Treatment Product
7.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
7.13 USGI Medical (U.S.)
7.13.1 Company profile
7.13.2 Representative Obesity Treatment Product
7.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
7.14 Olympus Corporation (Japan)
7.14.1 Company profile
7.14.2 Representative Obesity Treatment Product
7.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.15 Brunswick Corporation (U.S.)
7.15.1 Company profile
7.15.2 Representative Obesity Treatment Product
7.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
7.16 Technogym SpA (Italy)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
8.1 Industry Chain of Obesity Treatment
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
9.1 Cost Structure Analysis of Obesity Treatment
9.2 Raw Materials Cost Analysis of Obesity Treatment
9.3 Labor Cost Analysis of Obesity Treatment
9.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 10 MARKETING STATUS ANALYSIS OF OBESITY TREATMENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Obesity Treatment in This Report
1.2 Commercial Types of Obesity Treatment
1.2.1 Surgical & Implant Devices
1.2.2 Medication Therapy
1.2.3 Dietary
1.2.4 Other
1.3 Downstream Application of Obesity Treatment
1.3.1 Children
1.3.2 Adults
1.4 Development History of Obesity Treatment
1.5 Market Status and Trend of Obesity Treatment 2013-2023
1.5.1 Global Obesity Treatment Market Status and Trend 2013-2023
1.5.2 Regional Obesity Treatment Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Obesity Treatment 2013-2017
2.2 Production Market of Obesity Treatment by Regions
2.2.1 Production Volume of Obesity Treatment by Regions
2.2.2 Production Value of Obesity Treatment by Regions
2.3 Demand Market of Obesity Treatment by Regions
2.4 Production and Demand Status of Obesity Treatment by Regions
2.4.1 Production and Demand Status of Obesity Treatment by Regions 2013-2017
2.4.2 Import and Export Status of Obesity Treatment by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Obesity Treatment by Types
3.2 Production Value of Obesity Treatment by Types
3.3 Market Forecast of Obesity Treatment by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Obesity Treatment by Downstream Industry
4.2 Market Forecast of Obesity Treatment by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OBESITY TREATMENT
5.1 Global Economy Situation and Trend Overview
5.2 Obesity Treatment Downstream Industry Situation and Trend Overview
CHAPTER 6 OBESITY TREATMENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Obesity Treatment by Major Manufacturers
6.2 Production Value of Obesity Treatment by Major Manufacturers
6.3 Basic Information of Obesity Treatment by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Obesity Treatment Major Manufacturer
6.3.2 Employees and Revenue Level of Obesity Treatment Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OBESITY TREATMENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 NutriSystem, Inc. (U.S.)
7.1.1 Company profile
7.1.2 Representative Obesity Treatment Product
7.1.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of NutriSystem, Inc. (U.S.)
7.2 Kellogg Company (U.S.)
7.2.1 Company profile
7.2.2 Representative Obesity Treatment Product
7.2.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Kellogg Company (U.S.)
7.3 Ethicon, Inc. (U.S.)
7.3.1 Company profile
7.3.2 Representative Obesity Treatment Product
7.3.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Ethicon, Inc. (U.S.)
7.4 Medtronic (U.S.)
7.4.1 Company profile
7.4.2 Representative Obesity Treatment Product
7.4.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.5 F. Hoffmann-La Roche (Switzerland)
7.5.1 Company profile
7.5.2 Representative Obesity Treatment Product
7.5.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche (Switzerland)
7.6 Atkins Nutritionals, Inc. (U.S.)
7.6.1 Company profile
7.6.2 Representative Obesity Treatment Product
7.6.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Atkins Nutritionals, Inc. (U.S.)
7.7 Herbalife Ltd. (U.S.)
7.7.1 Company profile
7.7.2 Representative Obesity Treatment Product
7.7.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Herbalife Ltd. (U.S.)
7.8 Covidien plc (U.S.)
7.8.1 Company profile
7.8.2 Representative Obesity Treatment Product
7.8.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Covidien plc (U.S.)
7.9 Apollo Endosurgery (U.S.)
7.9.1 Company profile
7.9.2 Representative Obesity Treatment Product
7.9.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Apollo Endosurgery (U.S.)
7.10 Amer Sports (Finland)
7.10.1 Company profile
7.10.2 Representative Obesity Treatment Product
7.10.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Amer Sports (Finland)
7.11 Johnson Health Technology, Ltd. (Taiwan)
7.11.1 Company profile
7.11.2 Representative Obesity Treatment Product
7.11.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Johnson Health Technology, Ltd. (Taiwan)
7.12 Cybex International (U.S.)
7.12.1 Company profile
7.12.2 Representative Obesity Treatment Product
7.12.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Cybex International (U.S.)
7.13 USGI Medical (U.S.)
7.13.1 Company profile
7.13.2 Representative Obesity Treatment Product
7.13.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of USGI Medical (U.S.)
7.14 Olympus Corporation (Japan)
7.14.1 Company profile
7.14.2 Representative Obesity Treatment Product
7.14.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.15 Brunswick Corporation (U.S.)
7.15.1 Company profile
7.15.2 Representative Obesity Treatment Product
7.15.3 Obesity Treatment Sales, Revenue, Price and Gross Margin of Brunswick Corporation (U.S.)
7.16 Technogym SpA (Italy)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OBESITY TREATMENT
8.1 Industry Chain of Obesity Treatment
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OBESITY TREATMENT
9.1 Cost Structure Analysis of Obesity Treatment
9.2 Raw Materials Cost Analysis of Obesity Treatment
9.3 Labor Cost Analysis of Obesity Treatment
9.4 Manufacturing Expenses Analysis of Obesity Treatment
CHAPTER 10 MARKETING STATUS ANALYSIS OF OBESITY TREATMENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
